Qing Li to Antineoplastic Agents
This is a "connection" page, showing publications Qing Li has written about Antineoplastic Agents.
Connection Strength
1.607
-
Doello S, Liang Z, Cho IK, Kim JB, Li QX. Cytotoxic Effects of 24-Methylenecyloartanyl Ferulate on A549 Nonsmall Cell Lung Cancer Cells through MYBBP1A Up-Regulation and AKT and Aurora B Kinase Inhibition. J Agric Food Chem. 2018 Apr 11; 66(14):3726-3733.
Score: 0.368
-
Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK. Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep. 2017 03 15; 7(1):201.
Score: 0.343
-
Li QQ, Hao JJ, Zhang Z, Hsu I, Liu Y, Tao Z, Lewi K, Metwalli AR, Agarwal PK. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. Int J Oncol. 2016 Jun; 48(6):2591-607.
Score: 0.321
-
Li QQ, Lee RX, Liang H, Zhong Y. Anticancer activity of ?-Elemene and its synthetic analogs in human malignant brain tumor cells. Anticancer Res. 2013 Jan; 33(1):65-76.
Score: 0.256
-
Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by ?-elemene in resistant human ovarian cancer cells. Med Oncol. 2013 Mar; 30(1):424.
Score: 0.256
-
Lee RX, Li QQ, Reed E. ?-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res. 2012 Aug; 32(8):3103-13.
Score: 0.062